Corteneinc
1 known investors
Cortene is developing a patent-protected, peptide-based drug targeting the brain signaling believed to underlie acquired chronic diseases such as Parkinson's, Alzheimer's, dysautonomia, autoimmunity, and ME/CFS. The company operates in biotech, focusing on the root causes of brain-centric chronic conditions.
Founders & leadership
Investors · 1
Competitors · 2
by search overlap1Mg4 shared keywordsTata 1mg is India's leading online pharmacy and healthcare platform that offers medicines, lab tests, doctor consultations, and cancer care services. The company operates a digital marketplace serving Indian consumers seeking pharmaceuticals, diagnostic testing, and medical advice.
Clene3 shared keywordsClene is a clinical-stage biopharmaceutical company developing nanotherapeutics that target cellular energy impairments to treat neurodegenerative diseases and restore neuronal health. Its platform produces clean-surfaced, catalytically-active nanocrystals for therapeutic use.
Companies competing with Corteneinc for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Corteneinc do?
- Cortene is developing a patent-protected, peptide-based drug targeting the brain signaling believed to underlie acquired chronic diseases such as Parkinson's, Alzheimer's, dysautonomia, autoimmunity, and ME/CFS. The company operates in biotech, focusing on the root causes of brain-centric chronic conditions.
- Who founded Corteneinc?
- Corteneinc was founded by Gerard Pereira.
- Who are Corteneinc's investors?
- Corteneinc's investors include Lauder Partners.